Human cytokine responses to coronary artery bypass grafting with and without cardiopulmonary bypass

Cremer, 1996, Systemic inflammatory response syndrome after cardiac operations, Ann Thorac Surg, 61, 1714, 10.1016/0003-4975(96)00055-0

Kolessov, 1967, Mammary artery-coronary artery anastomosis as method of treatment for angina pectoris, J Thorac Cardiovasc Surg, 54, 535, 10.1016/S0022-5223(19)43061-4

Cremer, 1997, Off-bypass coronary bypass grafting via minithoracotomy using mechanical epicardial stabilization, Ann Thorac Surg, 63, S79, 10.1016/S0003-4975(97)00338-X

Boonstra, 1997, Reoperative coronary bypass grafting without cardiopulmonary bypass through a small thoracotomy, Ann Thorac Surg, 63, 405, 10.1016/S0003-4975(96)00896-X

Wan, 1997, Cytokine responses to cardiopulmonary bypass, Ann Thorac Surg, 63, 269, 10.1016/S0003-4975(96)00931-9

Kirklin, 1983, Complement and the damaging effects of cardiopulmonary bypass, J Thorac Cardiovasc Surg, 86, 845, 10.1016/S0022-5223(19)39061-0

Gu, 1996, Leukocyte depletion results in improved lung function and reduced inflammatory response after cardiac surgery, J Thorac Cardiovasc Surg, 112, 494, 10.1016/S0022-5223(96)70277-5

Gillinov, 1994, Inhibition of neutrophil adhesion during cardiopulmonary bypass, Ann Thorac Surg, 57, 126, 10.1016/0003-4975(94)90380-8

Jansen, 1996, Cardiopulmonary bypass with modified fluid gelatin and heparin-coated circuits, Br J Anaesth, 76, 13, 10.1093/bja/76.1.13

Wan, 1996, Steroid administration in heart and heart-lung transplantation, Ann Thorac Surg, 61, 674, 10.1016/0003-4975(95)01059-9

Wan, 1996, Human cytokine responses to cardiac transplantation and coronary artery bypass grafting, J Thorac Cardiovasc Surg, 111, 469, 10.1016/S0022-5223(96)70458-0

Olthof, 1995, Interstitial fluid volume during cardiac surgery measured by means of a non-invasive conductivity technique, Acta Anaesthesiol Scand, 39, 508, 10.1111/j.1399-6576.1995.tb04109.x

Christakis, 1994, Determinants of low systemic vascular resistance during cardiopulmonary bypass, Ann Thorac Surg, 58, 1040, 10.1016/0003-4975(94)90451-0

Ranucci, 1996, Beneficial effects of Duraflo II heparin-coated circuits on postperfusion lung function, Ann Thorac Surg, 61, 76, 10.1016/0003-4975(95)00820-9

Zanardo, 1994, Acute renal failure in patients undergoing cardiac operation, J Thorac Cardiovasc Surg, 107, 1489, 10.1016/S0022-5223(94)70429-5

Plotz, 1993, Blood activation during neonatal extracorporeal life support, J Thorac Cardiovasc Surg, 105, 823, 10.1016/S0022-5223(19)34156-X

Bonser, 1991, Complement activation during bypass in acquired C1 esterase inhibitor deficiency, Ann Thorac Surg, 52, 541, 10.1016/0003-4975(91)90921-C

Oudemans-van Straaten, 1996, Increased oxygen consumption after cardiac surgery is associated with the inflammatory response to endotoxemia, Intensive Care Med, 22, 294, 10.1007/BF01700449

Hattler, 1995, Cytokine induction during cardiac surgery, J Cardiac Surg, 10, 418, 10.1111/j.1540-8191.1995.tb00671.x

Journois, 1994, Hemofiltration during cardiopulmonary bypass in pediatric cardiac surgery. Effects on hemostasis, cytokines, and complement components, Anesthesiology, 81, 1181, 10.1097/00000542-199411000-00011

Vey, 1996, Expression and cleavage of tumor necrosis factor-α and tumor necrosis factor receptorsby human monocytic cell lines upon direct contact with stimulated T cells, Eur J Immunol, 26, 2404, 10.1002/eji.1830261021

Radoux, 1994, The total cytokine concept, 251

Gu, 1998, Reduction of the inflammatory response in patients undergoing minimally invasive coronary artery bypass grafting, Ann Thorac Surg, 65, 420, 10.1016/S0003-4975(97)01127-2

Buffolo, 1996, Coronary artery bypass grafting without cardiopulmonary bypass, Ann Thorac Surg, 61, 63, 10.1016/0003-4975(95)00840-3

Cremer, 1997, Morbidity of cardiopulmonary bypass and potential benefits of minimally invasive coronary surgery, Cor Europaeum, 6, 164